Assessing swallowing function in patients with neurodegenerative diseases
Official title: Prospective Observational Study for the Systematic Assessment of Laryngopharyngeal Function in Patients With Neurodegenerative Diseases
Run by Kliniken Beelitz GmbH · NCT04706234 · Data updated 2026-11-12
This study looks at how well people with neurodegenerative diseases, like Parkinson's and Motor Neuron Disease, can swallow and how it affects their quality of life.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 350 (estimated) |
| Sponsor | Kliniken Beelitz GmbH Academic / other |
| Locations | 16 sites (Innsbruck, Tyrol and 15 other locations) |
| Status | Recruiting |
| Started | September 1, 2017 |
| Main results expected | December 31, 2027 |
| Study ends | July 31, 2028 |
| Registry record updated | April 9, 2025 |
| Trial ID | NCT04706234 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include patients diagnosed with Multiple System Atrophy, Progressive Supranuclear Palsy, Parkinson's Disease, Motor Neuron Disease, or other neurodegenerative diseases who have undergone laryngopharyngeal assessment.
✕Probably not a fit
Patients who do not consent to participate in the study will not benefit from its findings.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study systematically records the results of routine laryngeal examinations and specific characteristics of dysphagia in patients diagnosed with neurodegenerative disorders such as Multiple System Atrophy, Parkinson's Disease, and Motor Neuron Disease. It utilizes fiberoptic endoscopic evaluation of swallowing (FEES) and collects demographic and disease-specific data, along with administering two questionnaires related to swallowing disturbances and quality of life. The study aims to enhance understanding of laryngopharyngeal dysfunction and its implications for patient prognosis and treatment.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnostic tools and early interventions for dysphagia in patients with neurodegenerative diseases.
How similar studies have gone: While the systematic assessment of laryngopharyngeal function in neurodegenerative diseases is not extensively studied, the approach aligns with emerging diagnostic needs in the field, suggesting potential for success.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * diagnosis of probable or possible multiple system atrophy according to current consensus criteria (Gilman et al. 2008) or * diagnosis of probable or possible PSP according to the the Movement Disorders Society (MDS) diagnostic criteria (Höglinger et al. 2017) or * diagnosis of Parkinson's disease according to the MDS diagnostic criteria (Postuma et al 2015) * Hoehn and Yahr Stage within the range of I-V or * diagnosis of motor neurone disease or * diagnosis of a neurodegenerative disease other than specified above AND underwent laryngopharyngeal assessment according to the systematic task protocol during FEES (Warnecke et al. 2019). Exclusion Criteria: \- Patients who do not sign the consent form
Where it's running
-
Department of Neurology and Department of ENT, Medical University Innsbruck
Innsbruck, Tyrol, Austria Recruiting -
Department of Neurology, Medical University of Ulm
Ulm, Baden-Wurttemberg, Germany Recruiting -
Movement Disorders Hospital - Kliniken Beelitz
Beelitz-Heilstätten, Brandenburg, Germany Recruiting -
Department of Neurology, Medical School Hannover
Hanover, Lower Saxony, Germany Recruiting -
Department of Neurology, University Hospital Münster
Münster, North Rhine-Westphalia, Germany Recruiting -
Department of Neurology, University Hospital Carl Gustav Carus
Dresden, Saxony, Germany Recruiting
Show 10 more locations
-
Department of Neueology Asklepios Klinik Stadtroda
Stadtroda, Thuringia, Germany Recruiting -
Asklepios Fachklinikum Stadtroda
Stadtroda, Thuringia, Germany Recruiting -
Asklepios Klinik Barmbek
Hamburg, Germany Recruiting -
Department of Neurology Asklepios Klinik Barmbek
Hamburg, Germany Recruiting -
Department of Neurology, Movement Disorders Unit, Medical Center Tel Aviv
Tel Aviv, Israel Recruiting -
IRCCS Istituto delle Scienze Neurologiche, Azienda USL di Bologna
Bologna, Italy Recruiting -
Department of Neurology, Gifu University Graduate School of Medicine
Gifu, Japan Recruiting -
Department of Neurology, Medical University Warsaw
Warsaw, Poland Recruiting -
Department of Neurology SNUCM
Seoul, South Korea Recruiting -
Unidad de Parkinson y Trastornos del Movimiento Instituto Clínic de Neurociencias, Hospital Clinic de Barcelona
Barcelona, Catalonia, Spain Recruiting
Study contacts
- Principal investigator: Florin Gandor, MD — Movement Disorders Hospital Beelitz-Heilstätten, Germany
- Study coordinator: Florin Gandor, MD
- Email: gandor@kliniken-beelitz.de
- Phone: +493320422781
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Neurodegenerative Diseases Registry
This registry collects data from adults with neurodegenerative conditions to help doctors distinguish between Parkinsonian syndromes and related disorders and understand disease progression over time.
-
Collecting data on neurodegenerative diseases progression markers
This study is trying to find new signs that can help doctors understand how neurodegenerative diseases like Parkinson's progress, so they can improve early treatment options for patients.
-
Biobank for studying ALS and Alzheimer's diseases
This study is collecting blood, skin samples, and health information from people to see how genetics might help us understand and find treatments for ALS and Alzheimer's disease.
-
Using neuroimaging to improve diagnosis and prognosis of Parkinson's disease and related conditions
This study is trying to find brain imaging markers that can help doctors better diagnose and predict how Parkinson's disease and similar conditions will progress in patients.
-
A study on early diagnosis and biomarkers for dementia and related diseases
This study is testing new ways to spot dementia and related diseases early by looking for specific markers in the brain and body, to help people at high risk and track how well new treatments are working.
-
Registering medical data and care outcomes for ALS, SMA, and other motor disorders
This registry slowly collects routine-care information from adults with ALS, SMA, or other motor disorders to see how they’re treated and how care affects outcomes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.